AV
BIO icon

ASR Vermogensbeheer’s Bio-Rad Laboratories Class A BIO Stock Holding History

ASR Vermogensbeheer’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,137
Closed -$319K – 535
2025
Q3 		$319K Sell
1,137
-13
-1% -$3.54K ﹤0.01% 520
2025
Q2 		$278K Sell
1,150
-743
-39% -$176K ﹤0.01% 534
2025
Q1 		$461K Buy
+1,893
New +$569K 0.01% 495

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ASR Vermogensbeheer's BIO Position: Q4 2025 in Review

ASR Vermogensbeheer sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 1,137 shares — an estimated $319K sold.

ASR Vermogensbeheer first reported a position in BIO in Q1 2025 and held it in 3 quarters. The position peaked at $461K in Q1 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

  • ASR Vermogensbeheer reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
  • ASR Vermogensbeheer sold 1,137 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $319K.
  • ASR Vermogensbeheer first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and held it in 3 quarters.
  • ASR Vermogensbeheer's Bio-Rad Laboratories Class A position peaked at $461K in Q1 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on ASR Vermogensbeheer's 13F filing for Q4 2025, filed 3 Feb 2026.